Terms: = Colorectal cancer AND MSI2, ENSG00000153944, 124540 AND Prognosis
4 results:
1. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression.
Kharin L; Bychkov I; Karnaukhov N; Voloshin M; Fazliyeva R; Deneka A; Frantsiyants E; Kit O; Golemis E; Boumber Y
PLoS One; 2021; 16(7):e0252132. PubMed ID: 34237057
[TBL] [Abstract] [Full Text] [Related]
3. Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression.
Mukund K; Syulyukina N; Ramamoorthy S; Subramaniam S
BMC Cancer; 2020 Apr; 20(1):317. PubMed ID: 32293332
[TBL] [Abstract] [Full Text] [Related]
4. Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.
Zong Z; Zhou T; Rao L; Jiang Z; Li Y; Hou Z; Yang B; Han F; Chen S
Cancer Med; 2016 Apr; 5(4):623-30. PubMed ID: 26775684
[TBL] [Abstract] [Full Text] [Related]
